You have 9 free searches left this month | to do more

pomalidomide

Pomalidomide is a drug used to treat Multiple Myeloma, Recurrent Plasma Cell Myeloma, Myeloma, and other conditions. Pomalidomide is being actively studied in 88 studies and prior, has been studied in 40.

Top SponsorsTop SitesTop Investigators
CelgeneMayo ClinicAndrew Yee, MD
Mayo ClinicDana-Farber Cancer InstituteBinod Dhakal
National Cancer Institute (NCI)Hackensack University Medical CenterAjai Chari
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Skin Kaposi Sarcoma
  • Pomalidomide
  • Baltimore, Maryland
  • +1 more
2021-09-02
Sep 2, 2021
U
Completed
  • Multiple Myeloma
  • Pomalidomide
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences, Myeloma Institute f
2021-03-30
Mar 30, 2021
S
Not yet recruiting
  • Relapsed, Refractory, Multiple Myeloma
  • Pomalidomide
  • +2 more
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
2021-02-17
Feb 17, 2021
N
Withdrawn
  • Multiple Myeloma
  • (no location specified)
2021-08-18
Aug 18, 2021
N
Active, not recruiting
  • Kaposi Sarcoma
  • Sarcoma, Kaposi
  • Pomalidomide
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-10-14
Oct 14, 2021
W
Recruiting
  • Multiple Myeloma
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
2021-11-18
Nov 18, 2021
O
Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Portland, Oregon
    OHSU Knight Cancer Institute
2021-10-19
Oct 19, 2021
N
Recruiting
  • Viral Associated Malignancies
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-11-18
Nov 18, 2021
P
Recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-02-17
Feb 17, 2021
N
Recruiting
  • Kaposi Sarcoma
  • liposomal doxorubicin
  • pomalidomide
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-11-16
Nov 16, 2021
C
Recruiting
  • Multiple Myeloma
  • Cleveland, Ohio
  • +1 more
2021-04-15
Apr 15, 2021
B
Completed
  • AL Amyloidosis
  • Boston, Massachusetts
    Boston Medical Center
2020-09-03
Sep 3, 2020
C
Active, not recruiting
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
2021-08-18
Aug 18, 2021
P
Active, not recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Poitiers, France
    CHU Poitiers
2021-06-25
Jun 25, 2021
H
Recruiting
  • Multiple Myeloma
  • Selinexor 60 MG
  • +6 more
  • Hackensack, New Jersey
    John Theurer Cancer Center
2021-06-04
Jun 4, 2021
A
Recruiting
  • Human Immunodeficiency Virus 1 Positive
  • Skin Kaposi Sarcoma
  • Laboratory Biomarker Analysis
  • Pomalidomide
  • Eldoret, Kenya
  • +2 more
2021-06-07
Jun 7, 2021
E
Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
2021-02-02
Feb 2, 2021
E
Recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
2021-10-05
Oct 5, 2021
M
Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +3 more
2021-10-28
Oct 28, 2021
O
Completed
  • Recurrent Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-06-10
Jun 10, 2021
S
Terminated
  • Refractory Multiple Myeloma
  • Aarau, Switzerland
  • +15 more
2021-06-07
Jun 7, 2021